Deal Ends Today·Save 35% annual plan
Anticoagulant (DOAC)Reviewed for 2026 plan year

Does Humana Cover Xarelto?

The verdict

Covered on most plans

Yes — Humana covers Xarelto for atrial fibrillation and VTE across its Medicare Part D plans, listed as a Tier 3 preferred brand on Humana's 2026 formularies (Basic Rx, Value Rx, and Group plans). As a Part D sponsor Humana must carry it at the IRA 2026 Maximum Fair Price of $197/month. The $2,100 annual out-of-pocket cap and CenterWell mail-order pharmacy are the key cost levers.

MedicareCovered
CommercialCovered
See the difference

Coverage is set by your specific plan and formulary. This is a research summary — always confirm with Humana using your member ID.

Reviewed for 2026
Checked against the active plan year
Sourced from formularies
Humana drug lists + CMS guidance
Updated as rules change
Coverage and prior-auth criteria shift often
Verify before you decide
Informational only — not insurance advice

Key facts

  • Xarelto's 2026 IRA Maximum Fair Price is $197/30-day supply — a 62% reduction from the $517 list price, mandatory for all Medicare Part D plans including Humana.

    CMS. Medicare Drug Price Negotiation Program — Initial Price Applicability Year 2026.

  • The 2026 Medicare Part D out-of-pocket cap is $2,100 — after this threshold, all Part D drugs including Xarelto cost $0 for the remainder of the plan year.

    CMS Final CY 2026 Part D Redesign Program Instructions.

  • USC Schaeffer/JAMA found that average Eliquis out-of-pocket in stand-alone Part D more than doubled from $46.76 to $102.32 between 2020 and 2024 as plans shifted to coinsurance — the same coinsurance-shift dynamic applies to Xarelto in 2026.

    USC Schaeffer Center for Health Policy and Economics / JAMA, February 14, 2025.

Plan types

Medicare vs. commercial coverage

Whether Humana covers Xarelto depends heavily on which kind of plan you hold. They follow completely different rules — here's each one, side by side.

Medicare

Part D & Advantage plans

Covered

Xarelto is listed as a Tier 3 preferred brand on Humana's 2026 Part D formularies alongside Eliquis. The IRA Maximum Fair Price of $197/30-day supply (62% off the $517 list price) applies to all Humana Part D plans effective January 1, 2026. However, this is a payer-side price ceiling — whether your plan uses a fixed copay or coinsurance determines your actual per-fill amount. Per USC Schaeffer/JAMA analysis, many Part D plans shifted DOAC and other IRA-negotiated drugs from fixed copays to coinsurance in 2026, which can mean higher per-fill costs for some enrollees despite the lower negotiated price. The $2,100 out-of-pocket cap is the hard annual ceiling — once reached, Xarelto is $0 for the rest of the year. Quantity limits are common at this dose range; confirm your plan allows the full month's supply. PA/step therapy uncommon on Humana Medicare. Using CenterWell (Humana's mail-order and preferred retail pharmacy) typically provides the lowest Tier 3 cost-sharing. Medicare beneficiaries cannot use the Janssen commercial savings card.

Commercial / Employer

Group & marketplace plans

Covered

Humana's commercial and ACA footprint is limited compared to its Medicare business. Where Humana commercial plans are offered, Xarelto is typically covered at Tier 3 with quantity limits. Humana Medicaid MCOs cover Xarelto; prior authorization may be required per state Medicaid PDL at $0–$10 cost-share. Step therapy is not standard for a DOAC anticoagulant. The Janssen savings card ($0 for eligible commercially insured patients) applies only to commercial coverage — not Medicare or Medicaid. Verify coverage and cost on your specific Humana commercial or Medicaid plan formulary.

What you'll pay

Your cost, three ways

What Xarelto actually costs you swings enormously depending on how it's covered. Here's the realistic range.

No coverage

Paying cash

$500–$650/month retail (pharmacy-variable estimate; no generic Xarelto available as of 2026)

List price with no coverage — before any manufacturer savings card.

PA approved

With coverage

Tier 3 cost-share per plan phase; $2,100 annual OOP cap — verify exact copay or coinsurance on your Humana plan formulary

Typical monthly copay once prior authorization is approved.

Lowest cost

Bridge program

J&J/Janssen savings card — $0 for commercially insured patients only; not usable by Medicare or Medicaid beneficiaries. Janssen retired the 'Xarelto withMe Coverage Gap Support' program because Medicare eliminated the donut hole.

Reduced copay through the assistance program, where eligible.

IRA 2026 Maximum Fair Price: $197/30-day supply (effective 1/1/2026). MFP is a payer-side ceiling, not an automatic copay — fixed copay vs. coinsurance determines per-fill amount. CenterWell mail-order or preferred pharmacy typically provides the lowest Tier 3 cost-share on Humana plans. $2,100 out-of-pocket cap applies for 2026. All figures are estimates; verify with your specific Humana plan.

Do it yourself

Check YOUR exact coverage in 3 steps

General answers only get you so far. Here's how to confirm your own plan's decision in a few minutes.

  1. 1

    Look up Xarelto on the Humana formulary tool

    Log in to your Humana member portal at humana.com or call Humana Member Services at the number on your ID card. Use the drug formulary lookup to search 'Xarelto' and confirm the tier, quantity limits, and whether your plan charges a fixed copay or coinsurance at Tier 3 for the 2026 plan year.

  2. 2

    Confirm whether your plan uses a copay or coinsurance for Tier 3

    In 2026, many Part D plans shifted IRA-negotiated drugs like Xarelto from a fixed dollar copay to a percentage coinsurance. If your Humana plan uses coinsurance, your per-fill cost is a percentage of the $197 MFP. Ask Humana Member Services specifically: 'Does my plan charge a copay or coinsurance for Tier 3 brands?' This distinction determines your actual out-of-pocket each month.

  3. 3

    Fill at CenterWell or a Humana preferred pharmacy for lowest cost-share

    CenterWell is Humana's own mail-order and retail pharmacy network and typically offers the lowest Tier 3 cost-sharing on Humana Part D plans. Visit humana.com/pharmacy or call CenterWell at 1-800-379-0092. Medicare beneficiaries cannot use the Janssen savings card — the $2,100 annual cap is the primary protection against high annual costs.

If it's denied

Options if Humana won't cover Xarelto

A denial isn't the end of the road. These are the paths people commonly explore next — discuss any of them with your prescriber.

Eliquis (apixaban)

The other leading DOAC for AFib and VTE. Covered on Humana Part D as Tier 3 alongside Xarelto. Eliquis has a 2026 IRA MFP of $231 (vs. Xarelto's $197). The coinsurance-shift caveat is sharper for Eliquis — USC Schaeffer found average Eliquis OOP in stand-alone Part D more than doubled ($46.76 to $102.32) from 2020 to 2024. Clinical choice between the two is a decision for your physician.

Warfarin (generic coumadin)

An older anticoagulant available as a low-cost Tier 1 generic. Requires regular INR blood monitoring and dietary adjustments. Discuss with your physician whether this is appropriate if cost is a primary concern.

These options are listed for information only — your own clinician decides what is appropriate for you.

Frequently Asked Questions

Yes — Humana covers Xarelto for atrial fibrillation, VTE, and cardiovascular risk reduction on its 2026 Part D plans as a Tier 3 preferred brand. Humana's Part D formularies (Basic Rx, Value Rx, and Group plans) list Xarelto at Tier 3, the same tier as Eliquis. Step therapy is uncommon on Humana Medicare. Verify your specific plan's tier and quantity limits using the Humana formulary tool at humana.com.

Humana must carry Xarelto at the IRA 2026 Maximum Fair Price of $197/month — a 62% reduction from list price — but the MFP is a payer ceiling, not a guaranteed patient copay. Whether your plan charges a fixed dollar copay or a percentage coinsurance at Tier 3 determines your per-fill cost. The $2,100 out-of-pocket cap is the hard annual ceiling. CenterWell mail-order typically provides the lowest cost-share tier on Humana plans. Confirm your exact amount on the Humana formulary.

Prior authorization is not typical for Xarelto on Humana Medicare Part D plans — step therapy is uncommon for a DOAC anticoagulant. Quantity limits are standard, however, so confirm your plan allows the full month's supply at your prescribed dose. Humana Medicaid MCOs may require PA in some states per the state Medicaid PDL. Verify on your specific Humana plan drug list or call Member Services.

No — the J&J/Janssen Xarelto savings card is available only to commercially insured patients and cannot be used by Humana Medicare Part D or Medicaid members. Additionally, Janssen retired the 'Xarelto withMe Coverage Gap Support' program because Medicare eliminated the donut hole in 2025. For Humana Medicare members, the $2,100 annual out-of-pocket cap is the primary protection against high drug costs.

Not necessarily for every enrollee. The IRA Maximum Fair Price of $197 is what Humana pays for Xarelto — but 2026 brought a shift in how many Part D plans pass that price to patients. Plans using fixed copays may lower your per-fill cost; plans using coinsurance at Tier 3 may result in the same or higher amounts despite the lower negotiated price. The $2,100 annual cap ensures no enrollee pays more than that for all Part D drugs. Confirm whether your Humana plan uses a copay or coinsurance.

This content is for informational purposes only and does not constitute medical, financial, or insurance advice. Coverage rules, prior-authorization criteria, and copay amounts change frequently and vary by plan, formulary tier, and effective date — always verify current benefits directly with Humana before making any decision. Consult a licensed healthcare provider and your plan administrator for guidance specific to your situation.